FDA to Host Public Meeting on Establishing Rare Disease Innovation Hub

Summary

The US Food and Drug Administration (FDA) is hosting a public meeting to discuss the establishment of a Rare Disease Innovation Hub, which aims to enhance collaboration and advance therapies for rare diseases, and is open to input from patients, caregivers, industry organizations, and scientific/academic groups.